Ibaraki, Japan

Kyoko Nakanishi

This inventor holds 11 USPTO granted patents. Top assignees: Suntory Limited, Daiichi Suntory Pharma Co., Ltd., Asubio Pharma Co. Ltd.. Active years: 1999-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyoko Nakanishi. Retrieved from https://idiyas.com/inventor/kyoko-nakanishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 36.4

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1999-2010

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Kyoko Nakanishi: Innovator in Pharmaceutical Chemistry

Introduction

Kyoko Nakanishi is a prominent inventor based in Ibaraki, Japan, known for her significant contributions to pharmaceutical chemistry. With a total of 11 patents to her name, she has made remarkable advancements in the development of compounds aimed at treating various medical conditions.

Latest Patents

Nakanishi's latest patents include innovative compounds such as arylipiperdinopropanol and arylipiperazinopropanol derivatives. These compounds are designed to suppress cytotoxic calcium overload and lipid peroxidation, making them effective for pharmaceutical preparations aimed at alleviating symptoms due to ischemic diseases. Another notable patent involves arylpiperidinol and arylpiperidine derivatives, which are particularly useful for treating symptoms related to ischemic diseases, seizures, epilepsy, and migraines.

Career Highlights

Throughout her career, Kyoko Nakanishi has worked with esteemed companies such as Suntory Limited and Daiichi Suntory Pharma Co., Ltd. Her work has significantly impacted the pharmaceutical industry, particularly in the development of medications that address critical health issues.

Collaborations

Nakanishi has collaborated with notable colleagues, including Hirokazu Annoura and Shigeki Tamura, contributing to her innovative research and development efforts.

Conclusion

Kyoko Nakanishi's work exemplifies the spirit of innovation in pharmaceutical chemistry. Her contributions continue to pave the way for advancements in medical treatments, showcasing her dedication to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…